Stocks
CSL LimitedCSLLY
OTCHealthcareBiotechnology$24.43-1.41%
An Australia-based biotechnology group specializing in plasma-derived therapies, recombinant proteins, and vaccines used to treat rare and serious diseases. Its core business, CSL Behring, manufactures immunoglobulins and other plasma therapies, while subsidiary Seqirus is a major global producer of...
Market Cap: $94.6B52W Range: $24.42 – $44.85
Congressional Interest in CSL Limited (CSLLY)
3 members of Congress have disclosed 6 trades in CSL Limited (CSLLY), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 5 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
6
Unique Politicians
3
Buys
1
Sells
5
Who in Congress Is Trading CSLLY?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-07-10 | Daniel Goldman | sell | $50K – $100K |
| 2023-02-27 | Daniel Goldman | buy | $15K – $50K |